BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 27429851)

  • 1. Synergistic reversal effect of epithelial-to-mesenchymal transition by miR-223 inhibitor and genistein in gemcitabine-resistant pancreatic cancer cells.
    Ma J; Zeng F; Ma C; Pang H; Fang B; Lian C; Yin B; Zhang X; Wang Z; Xia J
    Am J Cancer Res; 2016; 6(6):1384-95. PubMed ID: 27429851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of miR-223 reverses epithelial-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells.
    Ma J; Fang B; Zeng F; Ma C; Pang H; Cheng L; Shi Y; Wang H; Yin B; Xia J; Wang Z
    Oncotarget; 2015 Jan; 6(3):1740-9. PubMed ID: 25638153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of NEAT1 sensitizes gemcitabine-resistant pancreatic cancer cells to gemcitabine through modulation of the miR-506-3p/ZEB2/EMT axis.
    Fu X; Deng X; Xiao W; Huang B; Yi X; Zou Y
    Am J Cancer Res; 2021; 11(8):3841-3856. PubMed ID: 34522453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells.
    Li Y; VandenBoom TG; Kong D; Wang Z; Ali S; Philip PA; Sarkar FH
    Cancer Res; 2009 Aug; 69(16):6704-12. PubMed ID: 19654291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. lncRNA GAS5 Reverses EMT and Tumor Stem Cell-Mediated Gemcitabine Resistance and Metastasis by Targeting miR-221/SOCS3 in Pancreatic Cancer.
    Liu B; Wu S; Ma J; Yan S; Xiao Z; Wan L; Zhang F; Shang M; Mao A
    Mol Ther Nucleic Acids; 2018 Dec; 13():472-482. PubMed ID: 30388621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isocorydine decrease gemcitabine-resistance by inhibiting epithelial-mesenchymal transition via STAT3 in pancreatic cancer cells.
    Zhang QB; Ye RF; Ye LY; Zhang QY; Dai NG
    Am J Transl Res; 2020; 12(7):3702-3714. PubMed ID: 32774728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-206 regulates cisplatin resistance and EMT in human lung adenocarcinoma cells partly by targeting MET.
    Chen QY; Jiao DM; Wang J; Hu H; Tang X; Chen J; Mou H; Lu W
    Oncotarget; 2016 Apr; 7(17):24510-26. PubMed ID: 27014910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Astaxanthin inhibits gemcitabine-resistant human pancreatic cancer progression through EMT inhibition and gemcitabine resensitization.
    Yan T; Li HY; Wu JS; Niu Q; Duan WH; Han QZ; Ji WM; Zhang T; Lv W
    Oncol Lett; 2017 Nov; 14(5):5400-5408. PubMed ID: 29098031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-200b regulates epithelial-mesenchymal transition of chemo-resistant breast cancer cells by targeting FN1.
    Yang X; Hu Q; Hu LX; Lin XR; Liu JQ; Lin X; Dinglin XX; Zeng JY; Hu H; Luo ML; Yao HR
    Discov Med; 2017 Sep; 24(131):75-85. PubMed ID: 28972876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-652 inhibits acidic microenvironment-induced epithelial-mesenchymal transition of pancreatic cancer cells by targeting ZEB1.
    Deng S; Li X; Niu Y; Zhu S; Jin Y; Deng S; Chen J; Liu Y; He C; Yin T; Yang Z; Tao J; Xiong J; Wu H; Wang C; Zhao G
    Oncotarget; 2015 Nov; 6(37):39661-75. PubMed ID: 26498682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genistein inhibits cell growth and invasion through regulation of miR-27a in pancreatic cancer cells.
    Xia J; Cheng L; Mei C; Ma J; Shi Y; Zeng F; Wang Z; Wang Z
    Curr Pharm Des; 2014; 20(33):5348-53. PubMed ID: 24479798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel anti-cancer effect of genistein: reversal of epithelial mesenchymal transition in prostate cancer cells.
    Zhang LL; Li L; Wu DP; Fan JH; Li X; Wu KJ; Wang XY; He DL
    Acta Pharmacol Sin; 2008 Sep; 29(9):1060-8. PubMed ID: 18718175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-34a targets epithelial to mesenchymal transition-inducing transcription factors (EMT-TFs) and inhibits breast cancer cell migration and invasion.
    Imani S; Wei C; Cheng J; Khan MA; Fu S; Yang L; Tania M; Zhang X; Xiao X; Zhang X; Fu J
    Oncotarget; 2017 Mar; 8(13):21362-21379. PubMed ID: 28423483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The MiR-495/Annexin A3/P53 Axis Inhibits the Invasion and EMT of Colorectal Cancer Cells.
    Bai Z; Wang J; Wang T; Li Y; Zhao X; Wu G; Yang Y; Deng W; Zhang Z
    Cell Physiol Biochem; 2017; 44(5):1882-1895. PubMed ID: 29224019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of microRNA-145 promotes epithelial-mesenchymal transition via regulating Snail in osteosarcoma.
    Zhang Z; Zhang M; Chen Q; Zhang Q
    Cancer Gene Ther; 2017 Feb; 24(2):83-88. PubMed ID: 28186090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-139-5p affects cisplatin sensitivity in human nasopharyngeal carcinoma cells by regulating the epithelial-to-mesenchymal transition.
    Shao Q; Zhang P; Ma Y; Lu Z; Meng J; Li H; Wang X; Chen D; Zhang M; Han Y; Liu H; Ma S
    Gene; 2018 Apr; 652():48-58. PubMed ID: 29427737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-135b-5p Promotes migration, invasion and EMT of pancreatic cancer cells by targeting NR3C2.
    Zhang Z; Che X; Yang N; Bai Z; Wu Y; Zhao L; Pei H
    Biomed Pharmacother; 2017 Dec; 96():1341-1348. PubMed ID: 29196101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genistein down-regulates miR-223 expression in pancreatic cancer cells.
    Ma J; Cheng L; Liu H; Zhang J; Shi Y; Zeng F; Miele L; Sarkar FH; Xia J; Wang Z
    Curr Drug Targets; 2013 Sep; 14(10):1150-6. PubMed ID: 23834147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-451 induces epithelial-mesenchymal transition in docetaxel-resistant lung adenocarcinoma cells by targeting proto-oncogene c-Myc.
    Chen D; Huang J; Zhang K; Pan B; Chen J; De W; Wang R; Chen L
    Eur J Cancer; 2014 Nov; 50(17):3050-67. PubMed ID: 25310895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-132 suppresses the migration and invasion of lung cancer cells by blocking USP9X-induced epithelial-mesenchymal transition.
    Guo H; Zhang X; Chen Q; Bao Y; Dong C; Wang X
    Am J Transl Res; 2018; 10(1):224-234. PubMed ID: 29423007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.